NYSE · Medical - Devices

Medtronic plc (MDT) Stock

$95.41 -1.22% NYSE: MDT Healthcare

Valuation

MetricValue
Price$95.41
Market Cap$122.05B
P/E Ratio21.67
P/B Ratio2.26
P/S Ratio3.02
EPS (TTM)$3.61
52-Week High$106.33
52-Week Low$73.31
Dividend Yield3.25%

Financials & Margins

MetricValue
ROE10.60%
ROA5.61%
ROCE8.33%
Gross Margin17.76%
Operating Margin17.76%
Net Margin13.93%
Debt/Equity0.56
Current Ratio1.85

Annual Financials (USD)

Metric20222023202420252026
Revenue$31.7B$31.2B$32.4B$33.5B$36.4B
Operating Profit$5.8B$5.5B$5.1B$6.0B$6.5B
Net Profit$5.0B$3.8B$3.7B$4.7B$4.8B
EPS$3.73$2.82$2.76$3.61$3.73
Op Margin18.1%17.6%15.9%17.8%17.8%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$91.0B$90.9B$90.0B$91.7B—
Total Liabilities$38.3B$39.3B$39.6B$43.4B—
Cash$3.7B$1.5B$1.3B$2.2B—
Borrowings$24.1B$24.4B$25.0B$28.5B$0

Latest News

J&J Slipped On Its Report; Why It Bodes Well For Intuitive, Abbott, Others Investor's Business Daily · Jul 15, 2026 The Open Questions On ISRG Stock Trefis · Jul 15, 2026 Why This Group Of Medical Giants, Including Intuitive Surgical, Just Took A Tumble Investor's Business Daily · Jul 14, 2026 The Paid-To-Hold Play On ISRG Stock: A 12% Income Trefis · Jul 14, 2026 ISRG Stock: What Does Its Valuation Imply? Trefis · Jul 14, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$7.3B$6.0B$6.8B$7.0B$7.3B
Investing Cash Flow$-3.0B$-5.0B$-4.0B$-3.8B$-4.8B
Financing Cash Flow$-2.4B$-746.0M$-2.1B$-3.4B$-453.0M
Net Cash Flow$121.0M$-2.2B$-259.0M$934.0M$-269.0M
Free Cash Flow$6.0B$4.6B$5.2B$5.2B$5.4B

Valuation & Return Ratios

MetricValue
PEG Ratio1.71
EV / EBITDA14.81
FCF Yield5.40%
Quick Ratio2.09
Interest Coverage9.36
Return 1Y4.63%
Return 3Y46.28%
Return 5Y-8.68%

Ownership

Insiders Held0.31%
Institutions Held89.60%
Institutions Float Held89.88%
Institutional HolderSharesReport Date
Blackrock Inc.113,182,5672026-03-31
Vanguard Capital Management LLC83,333,8332026-03-31
State Street Corporation61,741,0142026-03-31
JPMORGAN CHASE & CO50,973,5412026-03-31
Capital Research Global Investors41,926,5902026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
688617.SSAPT Medical Inc. $256.00 +1.07% 37.72 $35.28B 0.40%
AVRAnteris Technologies Global Corp. $5.87 -2.17% -2.74 $572.08M 0.00%
BSXBoston Scientific Corporation $45.69 -0.70% 17.71 $66.22B 0.00%
EWEdwards Lifesciences Corporation $89.07 -1.13% 49.59 $51.34B 0.00%
GNGBYGetinge AB (publ) $23.97 +0.23% 23.72 $6.53B 2.13%

About Medtronic plc

Medtronic plc is led by CEO Geoffrey Straub Martha, employs 95,000 people, headquartered in Galway, US, publicly traded since 1973.

Medtronic plc (MDT) stock trades at $95.41 with a market capitalization of $122.05B. The stock is valued at a price-to-earnings (P/E) ratio of 21.67, price-to-book of 2.26, price-to-sales of 3.02. Over the past 52 weeks the stock has ranged between $73.31 and $106.33, and currently trades 10.3% below its 52-week high. It pays a dividend yielding 3.25%.

On profitability, Medtronic plc generates a return on equity (ROE) of 10.60%, return on capital employed of 8.33%, an operating margin of 17.76%, a net profit margin of 13.93%.

In its most recent fiscal year, Medtronic plc reported annual revenue of $36.4B, net profit of $4.8B. Over the last 5 fiscal years, revenue grew at an average annual rate of 3.8%, and net profit grew at an average annual rate of 5.9%. Over that span net profit grew faster than revenue, so net margin widened.

The balance sheet shows a debt-to-equity ratio of 0.56, a current ratio of 1.85, total assets of $91.7B, $2.2B in cash and equivalents.

MDT has an average daily trading volume of 14,231,397 shares, a beta of 0.57 (historically less volatile than the overall market).

Medtronic plc by the numbers, 2016–2026

Compounded, revenue has grown 3.8% a year over five years, 5.2% over three, 8.4% over the last twelve months. Net profit was $4.8B in 2026.

The most recent net margin is 13.93%. On a trailing twelve-month basis to Mar '26, revenue is $36.4B and net profit $4.8B.

Borrowings fell from $31.0B to $0, cash from operations was $7.3B in the latest year, positive in 10 of the last 11.

Return on equity has averaged 8.2% over five years, and was 9.7% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Medtronic plc (MDT) — frequently asked questions

What is Medtronic plc (MDT) stock price today?

Medtronic plc (MDT) is currently trading at $95.41, down 1.22% today.

What is MDT P/E ratio?

Medtronic plc's P/E ratio is 21.67. This is between 15x and 30x, around the typical market average of roughly 18-22x.

What is MDT return on equity (ROE)?

Medtronic plc's return on equity (ROE) is 10.60%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.

What is Medtronic plc's market cap?

Medtronic plc has a market capitalization of $122.05B.

Does MDT pay a dividend?

Yes. Medtronic plc currently yields 3.25%. Yield moves with the share price, so it changes daily even when the payment does not.

How much debt does MDT carry?

Medtronic plc has a debt-to-equity ratio of 0.56. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is MDT's profit margin?

Medtronic plc reports a net profit margin of 13.93% — the share of revenue left after every cost, including tax and interest.

What sector is MDT in?

Medtronic plc is classified under Healthcare, in the Medical - Devices industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is MDT listed on?

Medtronic plc trades on NYSE under the ticker MDT.

What is MDT's 52-week range?

Over the last year Medtronic plc has traded between $73.31 and $106.33.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens MDT currently matches

On the figures above, Medtronic plc passes the filters for 11 of our ready-made screens, among them Dividend Stocks, Blue Chip Dividend Stocks, S&P 500 Dividend Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Dividend StocksBlue Chip Dividend StocksS&P 500 Dividend StocksLarge Cap StocksStocks Under $100Large Cap Dividend StocksDividend Yield Over 3%NYSE Listed StocksStocks With PE Under 25Stocks With PE Under 30Debt to Equity Below 1 Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.